pharmaBank facilitates the development of life science technologies through its professional in-house team and access to capital markets.  pharmaBank positions itself in the development chain by acquiring promising technologies near to or at the Phase I clinical trial stage of development.  We add value by incubating these technologies through their ongoing technical and financial developmental stages.  This process continues up to a stock market listing, merger or trade sale as appropriate.

As an organisation for emerging biotechnology projects, pharmaBank offers the following capability for life science projects with commercial potential:

• Prospecting, selecting and validating life science projects;
• Internal IP services to “derisk” the venture;
• Establishing of seed capital and mezzanine funding;
• Management, incubation and mentoring services for new biotech companies; Technology transfer and IP licensing;
• Extensive global corporate alliances, networks  and partnering;
• Development of clinical trial programs;
• Coordination with appropriate regulatory authorities;
• Corporate strategies for start-up companies through to IPO development; and
• Creation of viable exit strategies for investors and companies.